This special publication is one in a series of protocols resulting from a collaborative research agreement between the National Institute of Standards and Technology (NIST) and Duke University's Center for the Environmental Implications of Nanotechnology (CEINT). The original version of this protocol (Ver. 1.0) was first posted on the CEINT web site (http://ceint.duke.edu) and it, along with any other previous version, is superseded by this updated special publication version. Updates to this protocol may be released in the future. Visit http://nist.gov/mml/np-measurement-protocols.cfm to check for revisions of this protocol or new protocols in the series.
Introduction
Toxicity and fate assessment are key elements in the evaluation of the environmental, health and safety risks of engineered nanomaterials (ENMs). While significant effort and resources have been devoted to the toxicological evaluation of many ENMs, including nanoscale TiO 2 [1] [2] [3] [4] , obtaining conclusive and reproducible results continues to be a challenge [5] . This can be traced in part to the lack of standardized dispersion protocols and the inconsistent application of dispersion procedures in relevant biological and environmental matrices [6, 7] . In order to address these issues, the National Institute of Standards and Technology (NIST) jointly with the Center for the Environmental Implications of Nanotechnology (CEINT) have developed a series of standardized and validated protocols for the dispersion of ENMs from a powdered material source for both human health and environmental testing applications. This protocol has been developed and validated using NIST Standard Reference Material (SRM) 1898 a . SRM 1898 consists of a widely studied and industrially relevant TiO 2 nanomaterial with broad commercial penetration and a production history dating back several decades [3, [8] [9] [10] .
While the procedures detailed in this series focus on the dispersion of SRM 1898 in specific aqueous media, it is believed that the adopted characterization, optimization and validation approaches can be more generally applied to the preparation of ENM dispersions in any relevant matrix. For this reason, and to allow for broader applicability, experimental details and discussions regarding the characterization, process optimization and validation steps adopted for the development of the dispersion method are detailed in a separate publication [11] .
Principles and scope
In this protocol, TiO 2 nanoparticle dispersions in relevant biological media are produced by following a series of steps applied to a stock TiO 2 aqueous nanoparticle dispersion. To prepare the stock TiO 2 aqueous dispersion, refer to the previous protocol in this series [12] . This protocol focuses on two representative media broadly used for in vitro assays: phosphatebuffered saline solution (PBS) and Dulbecco's Modified Eagle Medium containing 10 % fetal bovine serum (DMEM-FBS). In both cases, bovine serum albumin (BSA) is utilized as a stabilizing agent; series specific serum albumin has been demonstrated to function as a non specific biocompatible stabilizer [9, 13, 14] . This protocol is proposed for the preparation of dispersions for generic acute bioassay applications; its use for chronic toxicity evaluations is beyond the scope of this work and should be validated by use of proper controls.
The method described herein, if applied correctly, yields 100 g/mL monomodal nanoscale TiO 2 dispersions in PBS or DMEM-FBS, characterized by mean particle diameters of ≈ 75 nm (in PBS) and ≈ 83 nm (in DMEM-FBS) and pH values from 7.2 to 7.4 (in PBS) and ≈ 7.8 (in DMEM-FBS). The dispersions retain their particle size distribution for 48 h under relevant incubation conditions (in DMEM-FBS) and at room temperature (in PBS). Dispersions prepared following this protocol should be stored so as to minimize exposure to light (e.g., in amber vials). nanoparticle -sub-classification of ultrafine particle that is characterized by dimensions in the nanoscale (i.e., between approximately 1 nm and 100 nm) in at least two dimensions; also referred to as "nano-object" in ISO TS 80004-1 [16].
primary particle -the smallest discrete identifiable entity associated with a particle system; in this context, larger particle structures (e.g., aggregates and agglomerates) may be composed of primary particles.
aggregate -a discrete assemblage of primary particles strongly bonded together (i.e., fused, sintered or metallically bonded). agglomerate -assemblage of particles (including primary particles and/or smaller aggregates) held together by relatively weak forces (e.g., van der Waals, capillary or electrostatic), that may break apart into smaller particles upon further processing.
Note-Although we define them as distinct entities, the terms aggregate and agglomerate have often been used interchangeably to denote particle assemblies.
dispersion -used in the present context to denote a liquid (aqueous) in which particles are homogeneously suspended, or the process of creating a suspension in which discrete particles are homogeneously distributed throughout a continuous fluid phase; implies the intention to break down agglomerates into their principal components (i.e., primary particles and/or aggregates).
Reagents, materials and equipment

Reagents
4.1.1. 10 mg/mL stock TiO 2 aqueous nanoparticle dispersion.
Note-Refer to [12] for materials and guidelines for the preparation of the 10 mg/mL TiO2 aqueous dispersion. 
Dispersion in PBS
5.1.1. Prepare a 10 mg/mL stock TiO 2 aqueous nanoparticle dispersion, per [12] . 5.1.2. Prepare 50 mL of PBS (1x) by doing a 1:10 dilution of the PBS (10x) with DI water, i.e., add 5 mL of PBS (10x) to 45 mL of DI water. Measure the pH of the prepared PBS (1x).
5.1.3. Adjust the pH of the prepared PBS (1x) solution to a value in the 7.2 to 7.4 range by addition of 0.1 mol/L HCl (aq) and/or NaOH (aq) as needed. Mix thoroughly after each acid or base addition step to allow for proper homogenization and attainment of equilibrium pH.
Note-The pH range was selected as acceptable for typical biologically relevant assays. If other values are desired, the stability of the dispersions must be tested accordingly.
5.1.4. After addition of HCl (aq) and/or NaOH (aq) to achieve the desired pH, add an adequate amount of PBS (10x) to compensate for the dilution of the PBS (1x) solution by the water added with the acid or base solutions; e.g., if 2 mL of 0.1 mol/L HCl (aq) were added to the PBS (1x) to obtain the desired pH, then add 0.22 mL (2 x 0.11) PBS (10x). After pH adjustment and equilibration, verify that the pH of the obtained PBS (1x) is in the range from 7.2 to 7.4. , to yield a dispersion containing 100 g/mL TiO 2 and 1.6 mg/mL BSA in PBS (1x). The pH of the resulting dispersion should be comparable to that of the original buffer medium (5.1.4).
5.1.10. For toxicological assays, the user is advised to conduct a control for BSA in the test medium (1.6 mg/mL) without TiO 2 .
5.1.11. The resulting dispersion, stored in the 30 mL amber vial, retains its PSD for at least 48 h at room temperature. , to yield a 100 g/mL (TiO 2 ), 100 g/mL (BSA) dispersion in DMEM-FBS. The pH of the resulting dispersion should still be comparable to that of the original medium (5.2.2). This procedure results in a 1.1 % dilution of the DMEM FBS by the water added with the TiO 2 and BSA stocks.
5.2.8. If used for toxicological assessments, the user is advised to conduct separate control tests for the BSA (100 g/mL) in the medium and for the water-diluted medium (1.1 %), in the absence of TiO 2 .
5.2.9. The resulting dispersion, stored in the 30 mL amber vial, retains its PSD and pH (± 0.1 units) for at least 48 h under relevant incubation conditions (37 ºC, 90 % humidity, 5 % CO 2 atmosphere). 
Expected outcome
Dispersion in PBS
6.1.1. The obtained dispersions should have a white but translucent appearance if prepared using SRM 1898 or commercial P25.
Note-If source powders other than P25 are used, the appearance may vary depending on the final particle size, particle concentration and other factors.
9
Preparation of Nanoscale TiO2 Dispersions in Biological Test Media for Toxicological Assessment, Version 1.1 6.1. The expected size range was calculated from three independent replicates obtained following the prescribed procedure. Refer to the Appendix for details on the calculation of the expected size parameter ranges.
The volume-based mean particle diameter, as well as the D 10 and D 90 values, for aqueous P25 dispersions prepared following the protocol should be reported by the user to allow for comparison with the values specified herein. Refer to [18] for details on PSD characterization and validation criteria, as well as representative PSD profiles.
6.1.3 The pH of dispersions should be comparable (± 0.1 pH units) to the pH of the originating medium. The expected range for size parameters was calculated from three independent replicates obtained following the prescribed procedure. Refer to the Appendix for details on the calculation of the expected size parameter ranges.
Dispersion in DMEM with 10 % FBS
The volume-based mean particle diameter, as well as the D 10 and D 90 values, for aqueous P25 dispersions prepared following the protocol, should be reported by the user to allow for comparison with the values specified herein. Refer to [18] for details and discussions on PSD characterization and validation criteria, as well as illustrations of representative PSD profiles. 
